Nuveen New York Select Tax-Free Income Portfolio
NYSE:NXN
11.59 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1.661 | -3.815 | 1.66 | 3.331 | 1.569 | 2.638 | 1.749 | 2.414 | 2.476 | 2.444 | 2.604 | 2.713 | 0 |
Cost of Revenue
| 2.96 | 0.159 | 0.173 | 0.178 | 0.177 | 0.173 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -1.299 | -3.974 | 1.487 | 3.153 | 1.392 | 2.465 | 1.749 | 2.414 | 2.476 | 2.444 | 2.604 | 2.713 | 0 |
Gross Profit Ratio
| -0.782 | 1.042 | 0.896 | 0.947 | 0.887 | 0.934 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0.076 | 0.079 | 0.227 | 0.079 | 0.083 | 0.076 | 0.081 | 0.237 | 0.233 | 0.236 | 0.228 | 0.223 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0.076 | 0.079 | 0.227 | 0.079 | 0.083 | 0.076 | 0.081 | 0.237 | 0.233 | 0.236 | 0.228 | 0.223 | 0 |
Other Expenses
| 2.989 | 0.002 | -1.802 | 0.002 | 0.002 | 0.003 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 3.065 | 0.081 | 2.158 | 0.081 | 0.086 | 0.078 | 0.084 | 2.161 | 0.261 | 2.05 | 3.066 | 0.486 | 0 |
Operating Income
| -4.364 | -3.896 | -0.315 | 3.25 | 1.483 | 2.568 | 1.678 | 2.177 | 2.242 | 2.208 | 2.376 | 2.49 | 0 |
Operating Income Ratio
| -2.628 | 1.021 | -0.19 | 0.976 | 0.945 | 0.974 | 0.959 | 0.902 | 0.906 | 0.903 | 0.912 | 0.918 | 0 |
Total Other Income Expenses Net
| 7.351 | 0.159 | -1.931 | 0 | -0.43 | 0.603 | -0.371 | -1.935 | -0.033 | 2.28 | -2.841 | 0.704 | 0 |
Income Before Tax
| 2.987 | -3.897 | -0.315 | 3.25 | 1.483 | 2.56 | 1.665 | 0.242 | 2.209 | 4.488 | -0.465 | 3.195 | 0 |
Income Before Tax Ratio
| 1.799 | 1.021 | -0.19 | 0.976 | 0.945 | 0.97 | 0.952 | 0.1 | 0.892 | 1.836 | -0.179 | 1.177 | 0 |
Income Tax Expense
| 0 | 1.747 | 1.616 | 1.819 | 1.905 | 1.956 | 2.036 | -1.935 | -0.033 | 2.28 | -2.841 | 0.704 | 0 |
Net Income
| 2.987 | -3.897 | -0.315 | 3.25 | 1.483 | 2.56 | 1.665 | 0.242 | 2.209 | 4.488 | -0.465 | 3.195 | 0 |
Net Income Ratio
| 1.799 | 1.021 | -0.19 | 0.976 | 0.945 | 0.97 | 0.952 | 0.1 | 0.892 | 1.836 | -0.179 | 1.177 | 0 |
EPS
| 0.76 | -0.99 | -0.08 | 0.83 | 0.38 | 0.65 | 0.43 | 0.062 | 0.56 | 1.14 | -0.12 | 0.81 | 0 |
EPS Diluted
| 0.76 | -0.99 | -0.08 | 0.83 | 0.38 | 0.65 | 0.43 | 0.062 | 0.56 | 1.14 | -0.12 | 0.81 | 0 |
EBITDA
| 2.988 | -3.896 | -0.315 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA Ratio
| 1.8 | 1.021 | -0.19 | 0.976 | 0.945 | 0.974 | 0.959 | -0.802 | -0.013 | 0.933 | -1.091 | 0.26 | 0 |